Convergence of nanoimaging, physics and biology: Can engineering lead to a cancer cure?

Vadim Backman*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The development of new optical nanoimaging technologies and the physics-based modeling of gene expression can help decipher the gene expression code, elucidate early events in carcinogenesis, and lead to new physico-chemical approaches to anti-cancer therapy.

Original languageEnglish (US)
Title of host publicationCLEO
Subtitle of host publicationApplications and Technology, CLEO_AT 2017
PublisherOSA - The Optical Society
VolumePart F43-CLEO_AT 2017
ISBN (Print)9781943580279
DOIs
StatePublished - Jan 1 2017
EventCLEO: Applications and Technology, CLEO_AT 2017 - San Jose, United States
Duration: May 14 2017May 19 2017

Other

OtherCLEO: Applications and Technology, CLEO_AT 2017
CountryUnited States
CitySan Jose
Period5/14/175/19/17

Keywords

  • Medical optics and biotechnology: 170.0170
  • Medical optics and biotechnology: 170.1420 biology
  • Medical optics and biotechnology: 170.4580 optical diagnostics for medicine

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Convergence of nanoimaging, physics and biology: Can engineering lead to a cancer cure?'. Together they form a unique fingerprint.

  • Cite this

    Backman, V. (2017). Convergence of nanoimaging, physics and biology: Can engineering lead to a cancer cure? In CLEO: Applications and Technology, CLEO_AT 2017 (Vol. Part F43-CLEO_AT 2017). OSA - The Optical Society. https://doi.org/10.1364/CLEO_AT.2017.ATu3A.2